Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

A systems biology perspective on rational design of peptide vaccine against virus infections.

Chen J, Wang Y, Guo D, Shen B.

Curr Top Med Chem. 2012;12(12):1310-9. Review.

PMID:
22690678
2.

Virus-epitope vaccine design: informatic matching the HLA-I polymorphism to the virus genome.

Vider-Shalit T, Raffaeli S, Louzoun Y.

Mol Immunol. 2007 Feb;44(6):1253-61. Epub 2006 Aug 22.

PMID:
16930710
3.

Design of synthetic peptidic constructs for the vaccine development against viral infections.

Haro I, Gómara MJ.

Curr Protein Pept Sci. 2004 Dec;5(6):425-33. Review.

PMID:
15581414
4.

Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses.

Sirskyj D, Diaz-Mitoma F, Golshani A, Kumar A, Azizi A.

Immunol Cell Biol. 2011 Jan;89(1):81-9. doi: 10.1038/icb.2010.65. Epub 2010 May 11. Review.

PMID:
20458336
5.

Advances in antiviral vaccine development.

Graham BS.

Immunol Rev. 2013 Sep;255(1):230-42. doi: 10.1111/imr.12098. Review.

6.

Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.

Poland GA, Ovsyannikova IG, Kennedy RB, Haralambieva IH, Jacobson RM.

OMICS. 2011 Sep;15(9):625-36. doi: 10.1089/omi.2011.0032. Epub 2011 Jul 6. Review.

7.

Fish vaccine antigens produced or delivered by recombinant DNA technologies.

Leong JC, Anderson E, Bootland LM, Chiou PW, Johnson M, Kim C, Mourich D, Trobridge G.

Dev Biol Stand. 1997;90:267-77. Review.

PMID:
9270855
8.

The top five "game changers" in vaccinology: toward rational and directed vaccine development.

Kennedy RB, Poland GA.

OMICS. 2011 Sep;15(9):533-7. doi: 10.1089/omi.2011.0012. Epub 2011 Aug 4. Review.

9.

Vaccine and adjuvant design for emerging viruses: mutations, deletions, segments and signaling.

Bowick GC, McAuley AJ.

Bioeng Bugs. 2011 May-Jun;2(3):129-35. Epub 2011 May 1. Review.

10.

The hunt for new tuberculosis vaccines: anti-TB immunity and rational design of vaccines.

Xing Z.

Curr Pharm Des. 2001 Jul;7(11):1015-37. Review.

PMID:
11472252
11.

Next generation deep sequencing and vaccine design: today and tomorrow.

Luciani F, Bull RA, Lloyd AR.

Trends Biotechnol. 2012 Sep;30(9):443-52. doi: 10.1016/j.tibtech.2012.05.005. Epub 2012 Jun 20. Review.

PMID:
22721705
12.

New approaches in viral vaccine development.

Brown F.

Scand J Infect Dis Suppl. 1990;76:39-46. Review.

PMID:
1966307
13.

Peptide vaccines for viral diseases.

Francis MJ.

Sci Prog. 1990;74(293 Pt 1):115-30. Review.

PMID:
2267573
14.
15.

Viral respiratory diseases (ILT, aMPV infections, IB): are they ever under control?

Jones RC.

Br Poult Sci. 2010 Feb;51(1):1-11. doi: 10.1080/00071660903541378. Review.

PMID:
20390564
16.

Vaccinia vectors as candidate vaccines: the development of modified vaccinia virus Ankara for antigen delivery.

Sutter G, Staib C.

Curr Drug Targets Infect Disord. 2003 Sep;3(3):263-71. Review.

PMID:
14529359
17.

Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.

Brun A, Albina E, Barret T, Chapman DA, Czub M, Dixon LK, Keil GM, Klonjkowski B, Le Potier MF, Libeau G, Ortego J, Richardson J, Takamatsu HH.

Vaccine. 2008 Dec 2;26(51):6508-28. doi: 10.1016/j.vaccine.2008.09.044. Review.

PMID:
18838097
18.

Pathogenic epitopes, heterologous immunity and vaccine design.

Welsh RM, Fujinami RS.

Nat Rev Microbiol. 2007 Jul;5(7):555-63. Review.

PMID:
17558423
19.

Pox viruses as eukaryotic cloning and expression vectors: future medical and veterinary vaccines.

Taylor J, Paoletti E.

Prog Vet Microbiol Immunol. 1988;4:197-217. Review.

PMID:
3078866
20.

Vaccines and viral antigenic diversity.

Mumford JA.

Rev Sci Tech. 2007 Apr;26(1):69-90. Review.

PMID:
17633294
Items per page

Supplemental Content

Write to the Help Desk